|

Long-term Safety and Efficacy of GBG Study Participants

RECRUITINGSponsored by GBG Forschungs GmbH
Actively Recruiting
SponsorGBG Forschungs GmbH
Started2022-10-12
Est. completion2030-05-19
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05739591

Summary

The ETERNITY study is an international, multicenter, observational study that aims to follow up patients who have participated in a GBG trial for early breast cancer, even after the study has officially ended, in order to collect long-term data on survival, late or delayed adverse events, in addition to information related to pregnancy, fertility and other parameters impacting quality of life.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion criteria:

* Participation and treatment in a GBG clinical trial for early breast cancer.
* Prospective registration: Written informed consent according to local regulatory requirements prior to data and biomaterial collection.

Exclusion criteria:

* Participation and treatment in a non-GBG clinical trial for early breast cancer.
* Patients with advanced or metastatic breast cancer who have participated and received treatment in a GBG clinical trial.

Conditions2

Breast CancerCancer

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.